A South American amphibian could potentially hold the key in curing cirrhosis

December 6, 2017, University of Surrey

The unique liver function of a South American amphibian, Siphonops annulatus, could pave the way to finding a cure to the devastating liver condition cirrhosis, a new study published in the prestigious Journal of Anatomy reports.

Researchers from the University of Surrey (UK), the Federal University of São Paulo and the Butantan Institute in Brazil used an innovative 3-D liver cell examination to explore the liver function of this snake-like amphibian. During an in-depth examination, it was found that the liver of Siphonops annulatus produces blood cells throughout its lifetime and breaks down the protein collagen.

According to Dr. Robson Gutierre, a morphologist and leading author of this study, the South American amphibian has very unique liver cells, known as melanomacrophages, which can remove and break down collagen as part of its natural function. In the same species, melanomacrophages also naturally engulf basophils, helping to minimise unwanted inflammation and reduce the scar tissue which can lead to .

Cirrhosis occurs in response to damage to the liver. Chronic alcoholism, hepatitis or other harmful substances can promote the response of self-repair in the liver, mainly represented as a high production of collagen and scar formation (fibrosis). As cirrhosis progresses, liver functions such as detoxification and cleaning of blood, among others, become difficult.

Several treatment strategies for cirrhosis have been tried throughout the world, such as delaying or removing the underlying stimulus that causes scars to form. Other treatments have looked at the degradation and/or removal of collagen.

Co-author Dr. Augusto Coppi, lecturer in Veterinary Anatomy and stereologist at the University of Surrey, said: "The of this amphibian, Siphonops annulatus, may provide us with a unique opportunity to solve one of the most devastating illnesses of the liver.

"We do need further in-depth investigations into how this discovery could be translated into humans, but it may have the potential to alter how we view and treat this disease. We are constantly amazed by nature, and this particular and not-well-studied species of amphibian could help us find a way to stop or even reverse ."

Dr. Robson Gutierre from the Federal University of São Paulo said: "The ability this species has to break down its natural defences could also provide insight into immunity tolerance, a mechanism by which the liver can minimise unwanted inflammations. Immunity tolerance can be studied in this species because they produce pro-inflammatory cells in the hematopoietic liver throughout its whole life, without developing chronic inflammations."

Liver cirrhosis must be diagnosed early and the cause treated, but damage is rarely reversed. In the late stages, cirrhosis is life threatening. Every year more than 4,000 people in the UK die from cirrhosis and an estimated 700 people have to have a transplant each year to survive.

Researchers will continue to explore how this could be translated into humans.

Explore further: Cholesterol-lowering drugs may help patients with cirrhosis

More information: Robson Campos Gutierre et al. Melanomacrophage functions in the liver of the caecilian Siphonops annulatus, Journal of Anatomy (2017). DOI: 10.1111/joa.12757

Related Stories

Cholesterol-lowering drugs may help patients with cirrhosis

September 7, 2017
Statins used for the treatment of high cholesterol may have other beneficial effects, but there has been reluctance to prescribe them to patients with liver disease because of concerns that they may cause abnormal liver enzyme ...

Family of patients with NAFLD and cirrhosis are at increased risk of liver fibrosis

June 19, 2017
Non-alcoholic fatty liver disease (NAFLD) is a common disorder characterized by abnormal accumulation of fat in the liver. NAFLD is diagnosed in up to one in three adults and one in 10 children in the United States, and obesity ...

Risk of liver cancer low in patients with cirrhosis, study finds

February 1, 2017
The results of a study by researchers at The University of Nottingham suggest that the risk of liver cancer in patients with cirrhosis may be much lower than previously thought.

Drinking coffee may reduce the risk of liver cirrhosis

February 1, 2016
Regular consumption of coffee was linked with a reduced risk of liver cirrhosis in a review of relevant studies published before July 2015.

Cell therapy trial offers new hope to liver disease patients

November 24, 2014
Liver disease patients could be helped by a new cell therapy to treat the condition.

Altered microbiome linked to liver disease in adolescents with cystic fibrosis

February 18, 2015
A professor at the University of Colorado School of Medicine at the Anschutz Medical Campus and his colleagues have found a possible cause of liver disease in adolescents with cystic fibrosis.

Recommended for you

Lung-on-a-chip simulates pulmonary fibrosis

May 25, 2018
Developing new medicines to treat pulmonary fibrosis, one of the most common and serious forms of lung disease, is not easy.

Reconstructing Zika's spread

May 24, 2018
The urgent threat from Zika virus, which dominated news headlines in the spring and summer of 2016, has passed for now. But research into how Zika and other mosquito-borne infections spread and cause epidemics is still very ...

Tick bite protection: New CDC study adds to the promise of permethrin-treated clothing

May 24, 2018
The case for permethrin-treated clothing to prevent tick bites keeps getting stronger.

Molecular network boosts drug resistance and virulence in hospital-acquired bacterium

May 24, 2018
In response to antibiotics, a gene regulation network found in the bacterium Acinetobacter baumannii acts to boost both virulence and antibiotic resistance. Edward Geisinger of Tufts University School of Medicine and colleagues ...

Past use of disinfectants and PPE for Ebola could inform future outbreaks

May 24, 2018
Data from the 2014 Ebola virus outbreak at two Sierra Leone facilities reveal daily usage rates for disinfectant and personal protective equipment, informing future outbreaks, according to a study published May 24, 2018 in ...

Early lactate measurements appear to improve results for septic patients

May 24, 2018
On October 1, 2015, the United States Centers for Medicare and Medicaid Services (CMS) issued a bundle of recommendations defining optimal treatment of patients suffering from sepsis, a life-threatening response to infection ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.